Cargando…

Impact of Nutrition on Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is characterized by sustained vasoconstriction, vascular remodeling, inflammation, and in situ thrombosis. Although there have been important advances in the knowledge of the pathophysiology of PAH, it remains a debilitating, limiting, and rapidly progressive di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Callejo, María, Barberá, Joan Albert, Duarte, Juan, Perez-Vizcaino, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019983/ https://www.ncbi.nlm.nih.gov/pubmed/31936113 http://dx.doi.org/10.3390/nu12010169

Ejemplares similares

Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
por: Blanco, Isabel, et al.
Publicado: (2023)

Total, Bioavailable, and Free Vitamin D Levels and Their Prognostic Value in Pulmonary Arterial Hypertension
por: Callejo, Maria, et al.
Publicado: (2020)

Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome
por: Callejo, María, et al.
Publicado: (2018)

Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension
por: Morales-Cano, Daniel, et al.
Publicado: (2021)

Impact of Vitamin D Deficit on the Rat Gut Microbiome
por: Robles-Vera, Iñaki, et al.
Publicado: (2019)

Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
por: Pérez-Vizcaíno, Francisco
Publicado: (2020)

Transcriptomic profile of cationic channels in human pulmonary arterial hypertension
por: Perez-Vizcaino, Francisco, et al.
Publicado: (2021)

Updated Perspectives on Pulmonary Hypertension in COPD
por: Blanco, Isabel, et al.
Publicado: (2020)

Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension
por: Barberà, Joan Albert
Publicado: (2013)

Restoration of Vitamin D Levels Improves Endothelial Function and Increases TASK-Like K(+) Currents in Pulmonary Arterial Hypertension Associated with Vitamin D Deficiency
por: Callejo, Maria, et al.
Publicado: (2021)

Elevated pulmonary arterial pressure in Zucker diabetic fatty rats
por: Morales-Cano, Daniel, et al.
Publicado: (2019)

Nutritional status in pulmonary arterial hypertension
por: Kwant, Chermaine T., et al.
Publicado: (2022)

Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching
por: Chamorro, Virginia, et al.
Publicado: (2018)

Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry
por: Garcia, Agustin R., et al.
Publicado: (2023)

Pulmonary hypertension associated with COPD
por: Naeije, Robert, et al.
Publicado: (2001)

New Biochemical Insights into the Mechanisms of Pulmonary Arterial Hypertension in Humans
por: Bujak, Renata, et al.
Publicado: (2016)

Current status of pulmonary arterial hypertension in Korea
por: Jang, Albert Youngwoo, et al.
Publicado: (2019)

Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

The Flavonoid Quercetin Reverses Pulmonary Hypertension in Rats
por: Morales-Cano, Daniel, et al.
Publicado: (2014)

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease
por: Arshad, Hassaan B., et al.
Publicado: (2021)

Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study
por: Escribano-Subias, Pilar, et al.
Publicado: (2020)

Antiproliferative miR-212-5p: Promising RNA therapy for pulmonary hypertension
por: Perez-Vizcaino, Francisco, et al.
Publicado: (2022)

Recent advances in the management of pulmonary arterial hypertension
por: Tsai, Halley, et al.
Publicado: (2016)

The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension
por: Zeng, Wei-Jie, et al.
Publicado: (2012)

Pulmonary arterial hypertension: the burden of disease and impact on quality of life
por: Delcroix, Marion, et al.
Publicado: (2015)

Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives
por: Guillevin, Loïc, et al.
Publicado: (2013)

The Glycobiology of Pulmonary Arterial Hypertension
por: Vang, Shia, et al.
Publicado: (2022)

Pregnancy in pulmonary arterial hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Biomarkers in Pulmonary Arterial Hypertension
por: Hojda, Silvana Elena, et al.
Publicado: (2022)

Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
por: Koudstaal, Thomas, et al.
Publicado: (2020)

Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
por: Sakao, Seiichiro, et al.
Publicado: (2015)

Pulmonary arterial hypertension: an update
por: Hoendermis, E. S.
Publicado: (2011)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Benza, Raymond L., et al.
Publicado: (2022)

Impact of left ventricular late enhancement on pulmonary arterial hypertension in idiopathic dilated cardiomyopathy
por: Pérez-David, Esther, et al.
Publicado: (2015)

Is pulmonary arterial hypertension associated with schistosomiasis distinct from pulmonary arterial hypertension associated with portal hypertension?
por: Graham, Brian B., et al.
Publicado: (2023)

Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis
por: Torres-Castro, Rodrigo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5n518t466to0374aeaviu9ja7s